中草药

中药及其活性成分调控铁死亡治疗泌尿系肿瘤作用机制研究进展

PDF下载

中草药 | 综述 2026,57(3): 1149-1157

收起

中草药 |综述 2026 , 57 (3) : 1149 -1157

中药及其活性成分调控铁死亡治疗泌尿系肿瘤作用机制研究进展

全屏

孙瑞¹, 魏义举², 张会永³, 陈智慧¹, 于莉⁴, 吴威⁵

作者信息

通讯作者:

于莉

作者简介:

孙瑞: 孙瑞，硕士研究生，研究方向为经典方剂的临床应用与实验。E-mail:sunrui10290309@163.com

Research progress on mechanism of traditional Chinese medicine and its active compounds in treatment of urinary tract tumors by regulating ferroptosis

SUN Rui, WEI Yiju, ZHANG Huiyong, CHEN Zhihui, YU Li, WU Wei

Affiliations

doi: 10.7501/j.issn.0253-2670.2026.03.030

文章导航

摘要

收起

铁死亡作为以铁依赖性和脂质过氧化为主要特征的新型程序性细胞死亡方式，是抑制泌尿系肿瘤增殖、转移及逆转耐药性的重要靶点。中药及其活性成分因多靶点、低毒性的作用特点，在调控铁死亡领域具有独特优势，主要体现在对铁死亡关键通路的协同干预方面。研究表明，中药通过靶向调控铁稳态、促进脂质过氧化及抑制以谷胱甘肽过氧化物酶4为核心的抗氧化防御系统3大经典通路，促进泌尿系肿瘤细胞内铁过载并破坏氧化还原平衡诱导铁死亡，发挥抗肿瘤作用。通过对中药调控铁死亡防治泌尿系肿瘤作用机理进行系统综述，为其更深入的分子机制研究及更广泛的临床应用提供参考。

关键词

中药 / 黄酮 / 生物碱 / 萜类 / 青蒿素 / 泌尿系肿瘤 / 前列腺癌 / 膀胱癌 / 肾癌 / 铁死亡 / 信号通路

Abstract

收起

Ferroptosis, as a new type of programmed cell death characterized by iron dependence and lipid peroxidation, is an important target for inhibiting proliferation, metastasis and reversing drug resistance of urinary tumors. Traditional Chinese medicine (TCM) and its active compounds have unique advantages in the field of regulating ferroptosis due to their multi-target and low toxicity, mainly reflected in the synergistic intervention of key pathways of ferroptosis. Studies have shown that TCM plays an anti-tumor role by targeting the three classical pathways of regulating iron homeostasis, promoting lipid peroxidation and inhibiting the antioxidant defense system with glutathione peroxidase 4 as the core, promoting iron overload in urinary tumor cells and destroying the redox balance to induce ferroptosis. This article aims to systematically review the mechanism of TCM regulating ferroptosis in prevention and treatment of urinary tract tumors, in order to provide reference for its more in-depth molecular mechanisms research and wider clinical application.

Key words

traditional Chinese medicine / flavonoids / alkaloids / terpenoids / artemisinin / urinary tumors / prostate cancer / bladder cancer / kidney cancer / ferroptosis / signal pathways

引用本文

孙瑞, 魏义举, 张会永, 陈智慧, 于莉, 吴威. 中药及其活性成分调控铁死亡治疗泌尿系肿瘤作用机制研究进展. 中草药, 2026 , 57 (3) : 1149 -1157 . DOI: 10.7501/j.issn.0253-2670.2026.03.030

SUN Rui, WEI Yiju, ZHANG Huiyong, CHEN Zhihui, YU Li, WU Wei. Research progress on mechanism of traditional Chinese medicine and its active compounds in treatment of urinary tract tumors by regulating ferroptosis[J]. Chinese Traditional and Herbal Drugs, 2026 , 57 (3) : 1149 -1157 . DOI: 10.7501/j.issn.0253-2670.2026.03.030

基金

收起

国家自然科学基金面上项目(82473420);辽宁省卫健委中医药多学科交叉创新团队项目(LNZYYCXTD-JCCX-002);广东省教育厅高校重点科研平台项目(2022ZDZX2062)

参考文献

收起

文献

收起

参考文献引证文献

排序方式：

Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-263.
Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death [J]. Cell, 2012, 149(5): 1060-1072.
高升, 缪佰良, 莫淇舟, 等. 铁死亡在泌尿系肿瘤治疗中的研究进展 [J]. 现代肿瘤医学, 2023, 31(13): 2522-2526.
陈少昀, 马纯政, 常思思, 等. 呼吸系统疾病中线粒体依赖型铁死亡机制的研究进展 [J]. 临床肺科杂志, 2023, 28(2): 274-279.
Stockwell B R. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications [J]. Cell, 2022, 185(14): 2401-2421.
Koppula P, Zhuang L, Gan B Y. Cytochrome P450 reductase (POR) as a ferroptosis fuel [J]. Protein Cell, 2021, 12(9): 675-679.
Anandhan A, Dodson M, Shakya A, et al. Nrf2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8 [J]. Sci Adv, 2023, 9(5): eade9585.
Lei S Q, Chen C Y, Han F Y, et al. AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11- and FTL-mediated ferroptosis [J]. Cell Rep, 2023, 42(9): 113110.
Kim J W, Lee J Y, Oh M, et al. An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis [J]. Exp Mol Med, 2023, 55(8): 1620-1631.
Broadfield L A, Pane A A, Talebi A, et al. Lipid metabolism in cancer: New perspectives and emerging mechanisms [J]. Dev Cell, 2021, 56(10): 1363-1393.
Li D S, Li Y S. The interaction between ferroptosis and lipid metabolism in cancer [J]. Signal Transduct Target Ther, 2020, 5(1): 108.
姜全奥, 邓然, 夏仕林, 等. 脂滴代谢调控铁死亡的研究进展 [J]. 药学学报, 2024, 59(7): 1897-1904.
高倬桠, 王芝艳, 陈敬华, 等. ROS响应性不饱和脂肪酸脂质体促进肿瘤细胞铁死亡的研究 [J]. 沈阳药科大学学报, 2024, 41(1): 65-72.
李昭伦, 孙文静, 刘晓明, 等. 茯苓酸通过Keap1-Nrf2/ HO-1途径抑制铁死亡缓解脂多糖诱导的肺损伤 [J]. 临床肺科杂志, 2024, 29(6): 888-893.
Dos Santos A F, Fazeli G, Xavier da Silva T N, et al. Ferroptosis: Mechanisms and implications for cancer development and therapy response [J]. Trends Cell Biol, 2023, 33(12): 1062-1076.
Yan H F, Zou T, Tuo Q Z, et al. Ferroptosis: Mechanisms and links with diseases [J]. Signal Transduct Target Ther, 2021, 6(1): 49.
Upadhyayula P S, Higgins D M, Mela A, et al. Dietary restriction of cysteine and methionine sensitizes gliomas to ferroptosis and induces alterations in energetic metabolism [J]. Nat Commun, 2023, 14(1): 1187.
Jiang X J, Peng Q, Peng M J, et al. Cellular metabolism: A key player in cancer ferroptosis [J]. Cancer Commun, 2024, 44(2): 185-204.
Yang H B, Zhang X F, Jia Z M, et al. Targeting ferroptosis in prostate cancer management: Molecular mechanisms, multidisciplinary strategies and translational perspectives [J]. J Transl Med, 2025, 23(1): 166.
Kumar R, Mendonca J, Owoyemi O, et al. Supraphysiologic testosterone induces ferroptosis and activates immune pathways through nucleophagy in prostate cancer [J]. Cancer Res, 2021, 81(23): 5948-5962.
Ghoochani A, Hsu E C, Aslan M, et al. Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer [J]. Cancer Res, 2021, 81(6): 1583-1594.
覃俊凯. TFRC在膀胱癌细胞T24的表达及在诱导膀胱癌铁死亡中的作用 [D]. 右江: 右江民族医学院, 2024.
Shen L L, Zhang J F, Zheng Z T, et al. PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer [J]. Int J Biol Sci, 2022, 18(14): 5459-5474.
Zhao Y, Ren P P, Yang Z Q, et al. Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis [J]. Oncol Rep, 2023, 49(1): 16.
An W X, Gupta R, Zhai K, et al. Current and potential roles of ferroptosis in bladder cancer [J]. Curr Med Sci, 2024, 44(1): 51-63.
Wang Q, Gao S, Shou Y, et al. AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FoxO3a-ACSL4 axis-regulated ferroptosis [J]. Int J Biol Sci, 2023, 19(4): 1266-1283.
Hao J F, Chen Q G, Feng Y M, et al. Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-Akt signaling pathway [J]. Cell Death Dis, 2023, 14(4): 247.
Chang K, Chen Y J, Zhang X Z, et al. DPP9 stabilizes Nrf2 to suppress ferroptosis and induce sorafenib resistance in clear cell renal cell carcinoma [J]. Cancer Res, 2023, 83(23): 3940-3955.
张丽君. 汉黄芩苷通过GSK3β/Nrf2通路诱导细胞铁死亡进而抑制前列腺癌的增殖和侵袭 [D]. 合肥: 安徽医科大学, 2023.
王君君, 李坚. 槲皮素通过抑制溶质载体家族7成员11表达诱导前列腺癌细胞铁死亡的临床研究 [J]. 中国性科学, 2022, 31(9): 42-46.
肖艳红, 姜明东, 林叶远, 等. 灯盏花乙素抑制人前列腺癌细胞系PC-3的增殖和迁移 [J]. 基础医学与临床, 2024, 44(9): 1229-1235.
Fu W, Xu L, Chen Y W, et al. Luteolin induces ferroptosis in prostate cancer cells by promoting TFEB nuclear translocation and increasing ferritinophagy [J]. Prostate, 2024, 84(3): 223-236.
Han S T, Lin F Y, Qi Y C, et al. HO-1 contributes to luteolin-triggered ferroptosis in clear cell renal cell carcinoma via increasing the labile iron pool and promoting lipid peroxidation [J]. Oxid Med Cell Longev, 2022, 2022: 3846217.
胡乃华. 黄芩苷通过下调FTH1诱导膀胱癌细胞铁死亡 [J]. 天然产物研究与开发, 2022, 34(3): 490.
Kong N, Chen X Y, Feng J, et al. Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1 [J]. Acta Pharm Sin B, 2021, 11(12): 4045-4054.
陈夏颖. 黄芩提取物黄芩苷对膀胱癌的药理作用研究 [D]. 杭州: 杭州师范大学, 2021.
Zhai J C, Tan R, Yuan S L, et al. Unveiling tectorigenin: A novel ferroptosis inducer targeting EGFR in bladder cancer [J]. Phytomedicine, 2025, 148: 157419.
Wang C, Jiang H M. Vitexin induces apoptosis and ferroptosis and suppresses malignant proliferation and invasion of bladder urothelial carcinoma through PI3K/ Akt-Nrf2 axis [J]. Lett Drug Des Discov, 2024, 21(11): 2135-2147.
Chen Z X, Li W Y, Jia B S, et al. Chrysin enhances sunitinib sensitivity in renal cell carcinoma by inducing ferroptosis via targeting PI3K/Akt/GPX4 pathway [J]. Toxicol Appl Pharmacol, 2025, 504: 117531.
李艳春. 异甘草素通过上调HO-1的表达诱导肾细胞癌发生铁死亡的机制研究 [D]. 郑州: 郑州大学, 2023.
Yu R, Zhou Y F, Shi S F, et al. Icariside II induces ferroptosis in renal cell carcinoma cells by regulating the miR-324-3p/GPX4 axis [J]. Phytomedicine, 2022, 102: 154182.
Zou P L, Li S H, He Q X, et al. Berberine inhibits prostate cancer progression by inducing ferroptosis: Evidence from network pharmacology [J]. Anticancer Drugs, 2025, 36(4): 271-279.
穆克飞, 叶纪伟, 沈远径, 等. 小檗碱诱导前列腺癌细胞铁死亡及其作用机制 [J]. 中国癌症防治杂志, 2023, 15(3): 278-284.
Liu S H, Tao Y, Wu S, et al. Sanguinarine chloride induces ferroptosis by regulating ROS/BACH1/HMOX1 signaling pathway in prostate cancer [J]. Chin Med, 2024, 19(1): 7.
Li S Y, Cao H W, Sun P, et al. Stachydrine hydrochloride induces cell senescence and ferroptosis of castration-resistant prostate cancer [J]. Naunyn Schmiedebergs Arch Pharmacol, 2025, 398(10): 14165-14173.
Xu A H, Xie Y, Han R B, et al. Dihydrochelerythrine induced ferroptosis via glutathione peroxidase 4 downregulation in prostate cancer cells [J]. Chem Biodivers, 2025, 22(11): e00968.
Yu Y, Huang X, Liang C Q, et al. Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer [J]. Eur J Pharmacol, 2023, 957: 176007.
Li L L, Lu J Z, Fu S J, et al. Evodiamine induces ferroptosis in prostate cancer cells by inhibiting TRIM26-mediated stabilization of GPX4 [J]. Chin Med, 2025, 20(1): 71.
Hu C Y, Wu H T, Shan Y S, et al. Evodiamine exhibits anti-bladder cancer activity by suppression of glutathione peroxidase 4 and induction of ferroptosis [J]. Int J Mol Sci, 2023, 24(7): 6021.
Du Y, Zhao H C, Zhu H C, et al. Ferroptosis is involved in the anti-tumor effect of lycorine in renal cell carcinoma cells [J]. Oncol Lett, 2021, 22(5): 781.
Sun C W, Sun X X, Chen Y G, et al. Platycodin D-mediated METTL16 downregulation promotes docetaxel treatment of prostate cancer by regulating ferroptosis [J]. BMC Cancer, 2025, 25(1): 1042.
孙煜曦. 山楂酸调控RM-1细胞增殖、自噬和铁死亡的功能及机制研究 [D]. 唐山: 华北理工大学, 2024.
Shen S Y, Xue G F, Zeng Z G, et al. Toosendanin promotes prostate cancer cell apoptosis, ferroptosis and M1 polarization via USP39-mediated PLK1 deubiquitination [J]. Naunyn Schmiedebergs Arch Pharmacol, 2025, 398(8): 10939-10949.
He Z, Shi J X, Zhu B, et al. Ginsenoside Rh₂ repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis [J]. Front Oncol, 2025, 15: 1633891.
Xu Y, Tong Y Y, Lei Z M, et al. Abietic acid induces ferroptosis via the activation of the HO-1 pathway in bladder cancer cells [J]. Biomed Pharmacother, 2023, 158: 114154.
Jin M, He K, Zhen S Q, et al. Asiaticoside enhances the effect of propofol on the invasion, ferroptosis and immune escape of bladder cancer [J]. Drug Dev Res, 2024, 85(6): e22242.
Yu X, He Z Q, Wang Z, et al. Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway [J]. Exp Cell Res, 2024, 438(2): 114053.
Sang J, Liu C K, Liu J, et al. Jolkinolide B synergistically potentiates the antitumor activity of GPX4 inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells [J]. Biochem Pharmacol, 2024, 223: 116194.
Zhao H D, Ding R M, Han J R. Ginsenoside Rh₄ facilitates the sensitivity of renal cell carcinoma to ferroptosis via the Nrf2 pathway [J]. Arch Esp Urol, 2024, 77(2): 119-128.
Luo R Y, Li S, Wang H H, et al. Thymoquinone suppresses cell growth and induces ferroptosis in renal cell carcinoma by reducing SERPINH1 expression [J]. Lett Drug Des Discov, 2025, 22(2): 100013.
Vakhrusheva O, Erb H H H, Bräunig V, et al. Artesunate inhibits the growth behavior of docetaxel-resistant prostate cancer cells [J]. Front Oncol, 2022, 12: 789284.
王思宇, 王宇. 基于GSH/GPX4探讨青蒿琥酯对膀胱癌T24细胞铁死亡的诱导作用 [J]. 中国现代应用药学, 2025, 42(8): 1268-1276.
洪庭. 青蒿素衍生物DHA/ARTS诱导肾癌细胞系786-0发生铁死亡的机制研究 [D]. 沈阳: 中国医科大学, 2020.
黄成丽, 林芳荣, 李根, 等. 青蒿素衍生物DHA/ARTS诱导肾癌细胞系786-0发生铁死亡的机制 [J]. 西部医学, 2022, 34(2): 178-184.
吕茜. 双氢青蒿素通过CMA依赖性FTH1降解促进ccRCC发生铁死亡 [D]. 沈阳: 中国医科大学, 2024.
Markowitsch S D, Schupp P, Lauckner J, et al. Artesunate inhibits growth of sunitinib-resistant renal cell carcinoma cells through cell cycle arrest and induction of ferroptosis [J]. Cancers, 2020, 12(11): 3150.
Yang X Y, Wang L H, Lin P Y, et al. Discovery of artesunate (ARS) PROTACs as GPX4 protein degraders for the treatment of bladder cancer [J]. Eur J Med Chem, 2025, 293: 117710.
安丽杰. 6-姜酚调控LPS介导前列腺癌细胞生长与上皮细胞间质转化机制研究 [D]. 宜春: 宜春学院, 2022.
Zou P L, Chen Z, He Q X, et al. Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis [J]. Prostate, 2024, 84(1): 64-73.
Chen Y Y, Hua W X, Huang Y H, et al. Polyphyllin VII enhances the sensitivity of prostate cancer cells to docetaxel by promoting mitochondrial dysfunction and inducing ferroptosis [J]. Chem Biol Drug Des, 2025, 105(2): e70053.
王力, 王甜, 杨萍. 华蟾素通过ROS/Nrf2对前列腺癌细胞增殖及铁死亡的调控作用 [J]. 分子诊断与治疗杂志, 2025, 17(5): 819-822.
贾默然, 邵轶群, 盛东亚, 等. 白花丹素调控Nrf-2/ Keap1信号通路诱导膀胱癌细胞铁死亡 [J]. 中国实验方剂学杂志, 2023, 29(20): 39-44.
李嘉伟. 白花丹醌抗膀胱癌的药理活性及分子靶点 [D]. 桂林: 桂林医学院, 2024.
Chen X, Lu J L, Li H, et al. Resveratrol induces oxidative stress and downregulates GPX4 and xCT to activate the ferroptosis pathway for anti-bladder cancer organoids [J]. J Cancer, 2025, 16(8): 2613-2625.
邵轶群, 盛东亚, 管永俊, 等. 杠柳苷元促进Nrf2降解并诱导铁死亡抑制膀胱癌的作用机制 [J]. 中国中药杂志, 2025, 50(20): 5790-5799.
Lai Y C, Peng Z P, He Z H, et al. Dioscin initiates dual roles in bladder cancer progression via miR-195-5p/ FASN/SLC3A2 axis-mediated cell death mechanisms [J]. Transl Oncol, 2025, 61: 102534.
项煜. 鼓槌石斛提取物毛兰素诱导膀胱癌细胞发生铁死亡的药理机制研究 [D]. 杭州: 杭州师范大学, 2023.
Shen H L, Geng Z X, Nie X L, et al. Erianin induces ferroptosis of renal cancer stem cells via promoting ALOX12/p53 mRNA N6-methyladenosine modification [J]. J Cancer, 2023, 14(3): 367-378.
陆雪峰. 去甲斑蝥素通过铁死亡途径调控肾细胞癌细胞增殖和凋亡的分子机制研究 [D]. 宁波: 宁波大学, 2021.
谢若鑫, 邱剑光, 王德娟, 等. 藤黄酸对肾透明细胞癌凋亡及铁死亡的影响 [J]. 中成药, 2023, 45(6): 2011-2016.
Xu B, Zhu W J, Peng Y J, et al. Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene [J]. Transl Cancer Res, 2021, 10(7): 3158-3167.
Lv D, Xiang Y, Song T, et al. HECTD2 as a target for veratric acid in the regulation of ferroptosis in renal cell carcinoma [J]. Amino Acids, 2024, 56(1): 57.
Zhang Y Y, Su F Z, Zhu E L, et al. A systematical review on traditional Chinese medicine treating chronic diseases via regulating ferroptosis from the perspective of experimental evidence and clinical application [J]. Chin Herb Med, 2025, 17(2): 246-260.
Xu W J, Ding J, Li B N, et al. Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7/m-TOR/SREBP1 pathway on prostate cancer [J]. Biofactors, 2023, 49(2): 438-456.
游赣花, 朱建国, 杨萌, 等. 三叶青乙酸乙酯提取物通过p53/SLC7A11/GPX4信号通路促进铁死亡抑制前列腺癌PC-3细胞增殖 [J]. 中华中医药杂志, 2024, 39(9): 4688-4693.
李煜桐, 宋杏钰, 赖天立, 等. 多组学探究白骨壤调控铁死亡抗前列腺癌的可能机制 [J]. 中国男科学杂志, 2025, 39(2): 24-33.
龙彦西. 铁死亡在白花蛇舌草治疗膀胱癌中的作用及其机制研究 [D]. 大连: 大连医科大学, 2024.
Bai K P, Long Y X, Yuan F, et al. Hedyotis diffusa injection modulates the ferroptosis in bladder cancer via CAV1/ JUN/VEGFA [J]. Int Immunopharmacol, 2025, 147: 113925.
游赣花, 安群英, 何娟, 等. 蛇莓提取物通过GPX4诱导铁死亡抑制肾癌细胞OS-RC-2增殖 [J]. 中国药理学通报, 2024, 40(4): 662-670.
朱健. 益气活血方经SLC7A11/GPX4通路诱导去势抵抗性前列腺癌铁死亡的机制研究 [D]. 北京: 中国中医科学院, 2022.
Fu W, Lin M X, Yan Y T, et al. Fuzheng Yiliu Decoction-medicated serum promotes ferroptosis in prostate cancer cells via PPARγ-PLIN2 pathway [J]. Andrologia, 2025, 2025(1): 1728853.
Cao H W, Wu X T, Gao R J, et al. QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo [J]. J Cancer, 2023, 14(12): 2236-2245.

2026年第57卷第3期

PDF下载

引用本文

BibTeX

文章信息

doi: 10.7501/j.issn.0253-2670.2026.03.030

接收时间：2025-09-11
首发时间：2026-09-08

补充材料

相关文章

文章信息

作者

出版历史

收稿日期：2025-09-11

基金

作者信息

参考文献

分享链接

https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.03.030

分享至

全文二维码

扫描看全文

引用本文

BibTeX

本文的引用情况

2种不同金属材料的力学参数

科 Family	属数 Number of genus	种数 Number of species	占总种数比例 Percentage of total species (%)	属 Genus	种数 Number of species	占总种数比例 Percentage of total species (%)
鹅膏菌科Amanitaceae	2	11	5.26	鹅膏菌属 Amanita	10	4.78
小菇科 Mycenaceae	2	12	5.74	丝盖伞属 Inocybe	5	2.39
多孔菌科 Polyporaceae	8	14	6.70	蜡蘑属 Laccaria	5	2.39
红菇科 Russulaceae	3	23	11.00	小皮伞属 Marasmius	6	2.87
				小菇属 Mycena	11	5.26
				光柄菇属 Pluteus	5	2.39
				红菇属 Russula	17	8.13
				栓菌属 Trametes	5	2.39

关闭全屏

BibTeX
EndNote
RefWorks
TxT